A Phase 3 Study of NTLA-2001 in ATTRv-PN
Trial details
- Registry ID
- NCT06672237
- Phase
- Phase 3
Drug identity checked against registry records
Also recorded as NTLA-2001
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Phase 3 Study of NTLA-2001 in ATTRv-PNNCT06672237 | Intellia Therapeutics | Phase 3 | Active not recruiting | 2027-07Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |